Flatiron Health
Contact SalesReal-world data and AI for oncology decisions
By Tanmay Verma, Founder · Last verified 30 May 2026
5.9k views
Added 7d ago
76/100Safe BetReal-world data and AI for oncology decisions
By Tanmay Verma, Founder · Last verified 30 May 2026
Affiliate disclosure: We earn a commission when you use our links. Editorial picks are independent. How we choose.
Buyer-first take: Flatiron Health leads in oncology-specific real-world data with proven AI tools like Telescope. Best for pharma and researchers needing regulatory-grade evidence, but its niche focus may not suit generalist healthcare AI needs.
Last verified: May 2026
Flatiron Health stands out in the oncology real-world evidence space, combining high-fidelity data with AI that is grounded in human expertise. Choose it if you need robust, publication-ready evidence to support drug development, regulatory submissions, or clinical decision-making at scale. The new Flatiron Telescope platform promises to deliver insights in minutes, which could accelerate research timelines significantly. However, pass if your needs are outside oncology or if you require a broad population health platform without deep clinical specialization. Its closest alternative might be Tempus or Syapse, but Flatiron's volume of data and publication count (2,000+ papers) gives it a distinct edge. Real-world usage caveat: Be prepared for a clinical-specialist integration process and likely engagement with their scientific team rather than a self-serve tool. Pricing is contact-based, reflecting enterprise deals with life sciences and healthcare systems.
Skip Flatiron Health if Skip Flatiron Health if you are a solo practitioner, a non-oncology clinic, or need a self-service tool with transparent pricing.
ASCO 2026 recurrence risk prediction model for early breast cancer.
ASCO 2026 publication on treatment patterns in high-risk prostate cancer.
How likely is Flatiron Health to still be operational in 12 months? Based on 6 signals including funding, development activity, and platform risk.
Flatiron Health provides real-world evidence and AI-powered insights to guide high-stakes oncology decisions. Designed for life sciences companies and point-of-care providers, the platform captures and analyzes data from millions of cancer patients globally, transforming it into actionable insights. Key features include a global oncology engine that ingests high-fidelity data, AI powered by human expertise, and a new AI platform called Flatiron Telescope that delivers insights in minutes. Flatiron's real-world data has informed over 2,000 publications, and its capabilities include predicting rapid progression in breast cancer via machine learning and analyzing biomarker testing rates. Compared to other real-world evidence platforms, Flatiron Health emphasizes data quality and clinical depth, with a strong track record in academic and regulatory settings.
Tell us what you want to build — we'll match the AI tools that fit your goal, budget & existing stack.
Concrete scenarios for the personas Flatiron Health actually fits — and what changes day-one when you adopt it.
A scientist needs to generate real-world evidence for a label expansion submission to the FDA.
Outcome: Uses Flatiron's RWE solutions to access a fit-for-purpose cohort from 5M+ records, produces regulatory-grade analysis, and submits evidence faster than traditional methods.
A cancer center wants to standardize treatment regimens and reduce regimen variation across providers.
Outcome: Adopts Flatiron Assist, integrates NCCN guidelines, and sees a 44% reduction in unique regimens ordered, improving operational efficiency and patient outcomes.
Flatiron Health is a B2B platform with no self-service or free tier. Pricing is custom and likely high-cost. Access to full data and AI capabilities requires partnership agreements. Product documentation and tutorials are not publicly available.
The company stage and team size where Flatiron Health's pricing actually pencils out — and where peers do it cheaper.
Flatiron Health targets enterprise oncology organizations and pharma companies. Pricing is custom and not disclosed, but typical contracts likely exceed six figures annually. For smaller budgets, consider COTA or Syapse which may offer more transparent pricing.
How long it actually takes to get something useful out of Flatiron Health — broken out by persona, not the marketing-page minute.
Pharma RWE partnerships typically involve a scoping phase followed by data access setup. For clinicians, Flatiron Assist deployment can take weeks to months depending on practice size and EHR integration. No self-signup; requires direct sales engagement.
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
Pricing, brand, ownership, or deprecation changes worth knowing before you commit. Most-recent first.
Used Flatiron Health? Help shape our editorial sentiment research.
© 2026 RightAIChoice. All rights reserved.
Built for the AI community.
ASCO 2026 validation of digital twin models for counterfactual prediction in NSCLC.
Last calculated: May 2026
Durable execution platform for crash-safe AI agents and workflows.
